Robert Desha Hines Iv, MD | |
840 Montclair Rd, Suite 317, Birmingham, AL 35213-1920 | |
(205) 592-5135 | |
Not Available |
Full Name | Robert Desha Hines Iv |
---|---|
Gender | Male |
Speciality | Diagnostic Radiology |
Experience | 16 Years |
Location | 840 Montclair Rd, Birmingham, Alabama |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1396900197 | NPI | - | NPPES |
149973 | Medicaid | AL | |
149983 | Medicaid | AL | |
511-35200 | Other | AL | BLUE CROSS |
511-35201 | Other | AL | BLUE CROSS |
150147 | Medicaid | AL | |
511-35204 | Other | AL | BLUE CROSS |
148841 | Medicaid | AL | |
511-35202 | Other | AL | BLUE CROSS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2085B0100X | Radiology - Body Imaging | MD.30751 (Alabama) | Primary |
390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Secondary |
Facility Name | Location | Facility Type |
---|---|---|
St Vincent's Birmingham | Birmingham, AL | Hospital |
Brookwood Baptist Medical Center | Birmingham, AL | Hospital |
Riverview Regional Medical Center | Gadsden, AL | Hospital |
Russell Medical Center | Alexander city, AL | Hospital |
Usa Health University Hospital | Mobile, AL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Radiology Associates Of Birmingham, P.c. | 7214928571 | 37 |
News Archive
Isotechnika Pharma Inc. and Paladin Labs Inc. announced today that they have submitted the dossier and received screening acceptance for VocleraTM (voclosporin) for approval in the Canadian market. VocleraTM is a novel immunosuppressive drug in the class of calcineurin inhibitors and is indicated for the treatment of moderate to severe psoriasis.
Persons with Alzheimer's disease are able to manage their everyday activities longer and they suffer from less psychological and behavioural symptoms if the diagnosis is made and treatment begun at a very early phase of the disease, indicates a recent study conducted at the University of Eastern Finland.
Researchers at the University of California, San Diego (UCSD) Skaggs School of Pharmacy and Pharmaceutical Sciences have patented a strategy for developing a human vaccine to prevent against Human Cytomegalovirus (hCMV) infection and disease.
The University of Barcelona participates in the European project A-fit (Astronaut Exercise Prescriptions Promoting Health and Fitness on Earth), coordinated by the Karolinska Institute (Sweden). It aims at designing a fitness programme to avoid muscle atrophy associated to microgravity. Its results will contribute to the understanding of the beneficial effects of exercise in order to combat the effects of long-term muscle disuse. Findings may be also applied to other research areas, for instance, those diseases characterized by muscular dysfunction.
› Verified 9 days ago
Entity Name | Birmingham Radiological Group Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1376594192 PECOS PAC ID: 8022922756 Enrollment ID: O20031118000002 |
News Archive
Isotechnika Pharma Inc. and Paladin Labs Inc. announced today that they have submitted the dossier and received screening acceptance for VocleraTM (voclosporin) for approval in the Canadian market. VocleraTM is a novel immunosuppressive drug in the class of calcineurin inhibitors and is indicated for the treatment of moderate to severe psoriasis.
Persons with Alzheimer's disease are able to manage their everyday activities longer and they suffer from less psychological and behavioural symptoms if the diagnosis is made and treatment begun at a very early phase of the disease, indicates a recent study conducted at the University of Eastern Finland.
Researchers at the University of California, San Diego (UCSD) Skaggs School of Pharmacy and Pharmaceutical Sciences have patented a strategy for developing a human vaccine to prevent against Human Cytomegalovirus (hCMV) infection and disease.
The University of Barcelona participates in the European project A-fit (Astronaut Exercise Prescriptions Promoting Health and Fitness on Earth), coordinated by the Karolinska Institute (Sweden). It aims at designing a fitness programme to avoid muscle atrophy associated to microgravity. Its results will contribute to the understanding of the beneficial effects of exercise in order to combat the effects of long-term muscle disuse. Findings may be also applied to other research areas, for instance, those diseases characterized by muscular dysfunction.
› Verified 9 days ago
Entity Name | Norwood Clinic Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1104879741 PECOS PAC ID: 8921996364 Enrollment ID: O20040308001107 |
News Archive
Isotechnika Pharma Inc. and Paladin Labs Inc. announced today that they have submitted the dossier and received screening acceptance for VocleraTM (voclosporin) for approval in the Canadian market. VocleraTM is a novel immunosuppressive drug in the class of calcineurin inhibitors and is indicated for the treatment of moderate to severe psoriasis.
Persons with Alzheimer's disease are able to manage their everyday activities longer and they suffer from less psychological and behavioural symptoms if the diagnosis is made and treatment begun at a very early phase of the disease, indicates a recent study conducted at the University of Eastern Finland.
Researchers at the University of California, San Diego (UCSD) Skaggs School of Pharmacy and Pharmaceutical Sciences have patented a strategy for developing a human vaccine to prevent against Human Cytomegalovirus (hCMV) infection and disease.
The University of Barcelona participates in the European project A-fit (Astronaut Exercise Prescriptions Promoting Health and Fitness on Earth), coordinated by the Karolinska Institute (Sweden). It aims at designing a fitness programme to avoid muscle atrophy associated to microgravity. Its results will contribute to the understanding of the beneficial effects of exercise in order to combat the effects of long-term muscle disuse. Findings may be also applied to other research areas, for instance, those diseases characterized by muscular dysfunction.
› Verified 9 days ago
Entity Name | Radiology Associates Of Birmingham, P.c. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1093778706 PECOS PAC ID: 7214928571 Enrollment ID: O20040524001193 |
News Archive
Isotechnika Pharma Inc. and Paladin Labs Inc. announced today that they have submitted the dossier and received screening acceptance for VocleraTM (voclosporin) for approval in the Canadian market. VocleraTM is a novel immunosuppressive drug in the class of calcineurin inhibitors and is indicated for the treatment of moderate to severe psoriasis.
Persons with Alzheimer's disease are able to manage their everyday activities longer and they suffer from less psychological and behavioural symptoms if the diagnosis is made and treatment begun at a very early phase of the disease, indicates a recent study conducted at the University of Eastern Finland.
Researchers at the University of California, San Diego (UCSD) Skaggs School of Pharmacy and Pharmaceutical Sciences have patented a strategy for developing a human vaccine to prevent against Human Cytomegalovirus (hCMV) infection and disease.
The University of Barcelona participates in the European project A-fit (Astronaut Exercise Prescriptions Promoting Health and Fitness on Earth), coordinated by the Karolinska Institute (Sweden). It aims at designing a fitness programme to avoid muscle atrophy associated to microgravity. Its results will contribute to the understanding of the beneficial effects of exercise in order to combat the effects of long-term muscle disuse. Findings may be also applied to other research areas, for instance, those diseases characterized by muscular dysfunction.
› Verified 9 days ago
Entity Name | St Vincents Ambulatory Healthcare Network Llc |
---|---|
Entity Type | Part B Supplier - Independent Diagnostic Testing Facility (idtf) |
Entity Identifiers | NPI Number: 1588190441 PECOS PAC ID: 1355608456 Enrollment ID: O20171128001387 |
News Archive
Isotechnika Pharma Inc. and Paladin Labs Inc. announced today that they have submitted the dossier and received screening acceptance for VocleraTM (voclosporin) for approval in the Canadian market. VocleraTM is a novel immunosuppressive drug in the class of calcineurin inhibitors and is indicated for the treatment of moderate to severe psoriasis.
Persons with Alzheimer's disease are able to manage their everyday activities longer and they suffer from less psychological and behavioural symptoms if the diagnosis is made and treatment begun at a very early phase of the disease, indicates a recent study conducted at the University of Eastern Finland.
Researchers at the University of California, San Diego (UCSD) Skaggs School of Pharmacy and Pharmaceutical Sciences have patented a strategy for developing a human vaccine to prevent against Human Cytomegalovirus (hCMV) infection and disease.
The University of Barcelona participates in the European project A-fit (Astronaut Exercise Prescriptions Promoting Health and Fitness on Earth), coordinated by the Karolinska Institute (Sweden). It aims at designing a fitness programme to avoid muscle atrophy associated to microgravity. Its results will contribute to the understanding of the beneficial effects of exercise in order to combat the effects of long-term muscle disuse. Findings may be also applied to other research areas, for instance, those diseases characterized by muscular dysfunction.
› Verified 9 days ago
Entity Name | St Vincents Ambulatory Healthcare Network Llc |
---|---|
Entity Type | Part B Supplier - Independent Diagnostic Testing Facility (idtf) |
Entity Identifiers | NPI Number: 1033646823 PECOS PAC ID: 1355608456 Enrollment ID: O20180626000597 |
News Archive
Isotechnika Pharma Inc. and Paladin Labs Inc. announced today that they have submitted the dossier and received screening acceptance for VocleraTM (voclosporin) for approval in the Canadian market. VocleraTM is a novel immunosuppressive drug in the class of calcineurin inhibitors and is indicated for the treatment of moderate to severe psoriasis.
Persons with Alzheimer's disease are able to manage their everyday activities longer and they suffer from less psychological and behavioural symptoms if the diagnosis is made and treatment begun at a very early phase of the disease, indicates a recent study conducted at the University of Eastern Finland.
Researchers at the University of California, San Diego (UCSD) Skaggs School of Pharmacy and Pharmaceutical Sciences have patented a strategy for developing a human vaccine to prevent against Human Cytomegalovirus (hCMV) infection and disease.
The University of Barcelona participates in the European project A-fit (Astronaut Exercise Prescriptions Promoting Health and Fitness on Earth), coordinated by the Karolinska Institute (Sweden). It aims at designing a fitness programme to avoid muscle atrophy associated to microgravity. Its results will contribute to the understanding of the beneficial effects of exercise in order to combat the effects of long-term muscle disuse. Findings may be also applied to other research areas, for instance, those diseases characterized by muscular dysfunction.
› Verified 9 days ago
Entity Name | Cooper Green Mercy Health Services Authority An Affiliate Of Uab |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1366073108 PECOS PAC ID: 0840629473 Enrollment ID: O20200402003238 |
News Archive
Isotechnika Pharma Inc. and Paladin Labs Inc. announced today that they have submitted the dossier and received screening acceptance for VocleraTM (voclosporin) for approval in the Canadian market. VocleraTM is a novel immunosuppressive drug in the class of calcineurin inhibitors and is indicated for the treatment of moderate to severe psoriasis.
Persons with Alzheimer's disease are able to manage their everyday activities longer and they suffer from less psychological and behavioural symptoms if the diagnosis is made and treatment begun at a very early phase of the disease, indicates a recent study conducted at the University of Eastern Finland.
Researchers at the University of California, San Diego (UCSD) Skaggs School of Pharmacy and Pharmaceutical Sciences have patented a strategy for developing a human vaccine to prevent against Human Cytomegalovirus (hCMV) infection and disease.
The University of Barcelona participates in the European project A-fit (Astronaut Exercise Prescriptions Promoting Health and Fitness on Earth), coordinated by the Karolinska Institute (Sweden). It aims at designing a fitness programme to avoid muscle atrophy associated to microgravity. Its results will contribute to the understanding of the beneficial effects of exercise in order to combat the effects of long-term muscle disuse. Findings may be also applied to other research areas, for instance, those diseases characterized by muscular dysfunction.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Robert Desha Hines Iv, MD 2000a Southbridge Pkwy, Ste 300, Birmingham, AL 35209-7718 Ph: (205) 871-4274 | Robert Desha Hines Iv, MD 840 Montclair Rd, Suite 317, Birmingham, AL 35213-1920 Ph: (205) 592-5135 |
News Archive
Isotechnika Pharma Inc. and Paladin Labs Inc. announced today that they have submitted the dossier and received screening acceptance for VocleraTM (voclosporin) for approval in the Canadian market. VocleraTM is a novel immunosuppressive drug in the class of calcineurin inhibitors and is indicated for the treatment of moderate to severe psoriasis.
Persons with Alzheimer's disease are able to manage their everyday activities longer and they suffer from less psychological and behavioural symptoms if the diagnosis is made and treatment begun at a very early phase of the disease, indicates a recent study conducted at the University of Eastern Finland.
Researchers at the University of California, San Diego (UCSD) Skaggs School of Pharmacy and Pharmaceutical Sciences have patented a strategy for developing a human vaccine to prevent against Human Cytomegalovirus (hCMV) infection and disease.
The University of Barcelona participates in the European project A-fit (Astronaut Exercise Prescriptions Promoting Health and Fitness on Earth), coordinated by the Karolinska Institute (Sweden). It aims at designing a fitness programme to avoid muscle atrophy associated to microgravity. Its results will contribute to the understanding of the beneficial effects of exercise in order to combat the effects of long-term muscle disuse. Findings may be also applied to other research areas, for instance, those diseases characterized by muscular dysfunction.
› Verified 9 days ago
Dr. Garrett Colby, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 619 19th St S, Jt N342, Birmingham, AL 35249 Phone: 205-934-3108 Fax: 205-975-4413 | |
Drexell H Boggs, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1700 6th Ave S, Rm: 2253, Birmingham, AL 35233 Phone: 205-975-9399 Fax: 205-975-5184 | |
James Walker, Radiology Medicare: Accepting Medicare Assignments Practice Location: 1717 6th Ave S, Birmingham, AL 35233 Phone: 800-822-8816 | |
Joseph Smith, Radiology Medicare: Accepting Medicare Assignments Practice Location: 1717 6th Ave S, Birmingham, AL 35233 Phone: 800-822-8816 | |
Michelle M Mcnamara, MD Radiology Medicare: Medicare Enrolled Practice Location: 619 19th Street South, Birmingham, AL 35233 Phone: 205-934-4011 | |
Sharda Mehar Bajaj, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 1526 5th Ave S, Birmingham, AL 35233 Phone: 205-279-2860 | |
Gina Elizabeth Rebesco, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 625 19th St S, Birmingham, AL 35233 Phone: 205-975-0222 |